LSBio
SLC29A1 / ENT1 Antibody (N-Terminus)

SLC29A1 / ENT1 Antibody (N-Terminus)

Primary AntibodyLSBio Guarantee
Antibody:Rabbit Polyclonal
Applications:Enzyme-Linked Immunosorbent Assay, Immunohistochemistry (general), Western Blot
Reactivity:Human, Mouse, Rat
Format:Liquid
See all Human SLC29A1 / ENT1 antibodies →
$339.00each
Catalog Number: LS-C178673-100

For bulk orders or custom formulations:

Request a Quote

Overview

Description
ENT1 antibody LS-C178673 is an unconjugated rabbit polyclonal antibody to ENT1 (SLC29A1) (N-Terminus) from human. It is reactive with human, mouse and rat. Validated for ELISA, IHC and WB. Cited in 1 publication.
Application
ELISA, IHC, WB
Reactivity
Hu, Ms, Rt
Intended Use
Research Use Only
Guarantees
This antibody carries the LSBio 100% Guarantee.
Category
Antibodies > Primary Antibodies > Polyclonal Antibodies
Alternative Names
ENT1 | SLC29A1 | HENT1
Recommended Dilution: ELISA
1:10000 - 1:40000
Recommended Dilution: IHC
1:100 - 1:500
Recommended Dilution: WB
1:1000 - 1:2000
UniProt Number
Q99808
SwissProt
Q99808

Target

Target
Human SLC29A1 / ENT1
Antigen Species
Human
Epitope
Human SLC29A1 / ENT1.
Gene Name
SLC29A1

Antibody

Host Species
Rabbit
Clonality
Polyclonal

Immunogen

Immunogen
A peptide from N-Terminus residues of human SLC29A1 protein.
Immunogen Type
Peptide

Format

Conjugate/Label
Unconjugated
Format
Liquid
Formulation
PBS, pH 7.4, 0.02% Sodium Azide
Concentration
1 mg/mL
Preservative
Yes
Purification Method
Affinity Purified

Storage & Handling

Storage Conditions
Store at -20°C for up to 1 year.
Recommended Storage Buffer
PBS
The combination of everolimus and zoledronic acid increase the efficacy of gemcitabine in a mouse model of pancreatic adenocarcinoma. Vitellius C, Fizanne L, Menager-Tabourel E, Nader J, Baize N, Laly M, Lermite E, Bertrais S, Caroli-Bosc FX. Oncotarget. 2018 June;9:28069-28082. PubMed: 29963262 PMC: PMC6021353

Request SDS/MSDS

To request an SDS/MSDS form for this product, please contact our Technical Support department at: technical@vectorlabs.com.